Skip to content

Long-term Survival Analysis of Patients Undergoing Respiratory Intervention Treatment

Long-term Survival Analysis of Patients Undergoing Respiratory Intervention Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083551
Enrollment
Unknown
Registered
2024-04-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tracheal, bronchial, and pulmonary lesions

Interventions

Benign lesions group:None
Malignant lesions group:None

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1)Gender is not a limiting factor. 2)Age range: 18 to 85 years. 3)Patients who have previously received respiratory intervention treatment. 4)Lesions located in the trachea, main bronchus, and/or lungs (including secondary gastrointestinal-respiratory fistulas). 5)Informed consent obtained from the participant.

Exclusion criteria

Exclusion criteria: 1)Presence of other severe conditions that significantly affect survival, such as severe cardiovascular or immunological diseases. 2)Patients with non-esophageal cancers that cause secondary gastrointestinal-respiratory fistulas. 3)Death within 30 days post-surgery. 4)Incomplete treatment records or follow-up data.

Design outcomes

Secondary

MeasureTime frame
adverse reaction;complications ;

Primary

MeasureTime frame
Overall Survival;Progression-free survival;

Countries

China

Contacts

Public ContactHongwu Wang

Dongzhimen Hospital, Beijing University of Chinese Medicine

wanghongwu2015@126.com+86 139 1059 6991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026